Prospective Study Analyzing Value of Breast Density Change Predicting ENdocrine Therapy Response in Postmenopausal Women Taking Adjuvant ARomatase Inhibitor
Inclusion criteria ER positive breast cancer Postmenopause women Older than 60yr S/P
bilateral salphingo-oophorectomy No menstruation history within 1yr and FSH>30mIU/mL
Ipsilateral invasive breast cancer Undergone curative resection No evidence of distant
metastasis Capable of breast MRI
Observational [Patient Registry]
Observational Model: Cohort, Time Perspective: Prospective
disease free survival
recurrence locoregional distant metastasis Confirmed by clinical imaging or pathology
5 year
No
Wonshik Han, MD PhD
Principal Investigator
SNUH
Korea: Institutional Review Board
SNUHBCC001
NCT01765049
January 2013
December 2018
Name | Location |
---|